Urogynecological effects of menopause

References

• Blakeman PJ, Hilton P, Bulmer JN. Oestrogen and progestin receptor expression in the female lower urinary tract, with reference to oestrogen status. BJU Int. 86, 32–38 (2000).
   PubMed Web of Science ®Google Scholar
• Hendrix SL, Cochrane BB, Nygaard IE et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA 293, 935–948 (2005).
   PubMed Web of Science ®Google Scholar
• Girman CJ, Jacobsen SJ, Tsukamoto T et al. Health-related quality of life associated with lower urinary tract symptoms in four countries. Urology 51, 428–436 (1998).
   PubMed Web of Science ®Google Scholar
• Iosif CS, Batra S, Ek A, Astedt B. Estrogen receptors in the human female urinary tract. Am. J. Obstet. Gynecol. 141, 817–820 (1981).
   PubMed Web of Science ®Google Scholar
• Batra SC, Iosif CS. Progesterone receptors in the female lower urinary tract. J. Urol. 138, 1301–1304 (1987).
   PubMed Web of Science ®Google Scholar
• Panay N. Menopause and the postmenopausal woman. In: Dewhurst’s Textbook of Obstetrics and Gynaecology. Edmonds DK ( Ed.). Blackwell Publishing, Oxford, UK 479–495 (2008).
   Google Scholar
• O’Donnell P. Urodynamics evaluation in the elderly. Female Urol. 3, 961–970 (2008).
   Google Scholar
• Pierce LM, Baumann S, Rankin MR et al. Levator ani muscle and connective tissue changes associated with pelvic organ prolapse, parity and aging in the squirrel monkey: a histologic study. Am. J. Obstet. Gynecol. 97(1), 60 e1–e9 (2007)
   Google Scholar
• Hannestad YS, Rortveit G, Daltveit AK, Hunskaar S. Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPICONT Study. BJOG 110, 247–254 (2003).
   PubMed Web of Science ®Google Scholar
• Nihira MA, Henderson N. Epidemiology of urinary incontinence in women. Curr. Womens Health Rep. 3, 340–347 (2003).
   Google Scholar
• Kie Z, Shi H, Zhou C, Dong M, Hong L, Jin H. Alterations of estrogen receptor-α and -β in the anterior vaginal wall of women with urinary incontinence. Eur. J. Obstet. Gynecol. Reprod. Biol. 134, 254–258 (2007).
   Google Scholar
• Waetjen LE, Feng WY, Ye J et al. Factors associated with worsening and improving urinary incontinence across the menopausal transition. Obstet. Gynecol. 111, 667–677 (2008).
   PubMed Web of Science ®Google Scholar
• De Boer TA, Marijke CP, Hove ST, Burger CW, Vierhout ME. The prevalence and risk factors of overactive bladder symptoms and its relation to pelvic organ prolapse symptoms in a general female population. Int. Urogynecol. J. 22, 569–575 (2011).
   Google Scholar
• Pastore LM, Carter RA, Hulka BS, Wells E. Self-reported urogenital symptoms in postmenopausal women: women’s health initiative. Maturitas 49, 292–303 (2004).
   PubMed Web of Science ®Google Scholar
• Sarrel PM. Effects of hormone replacement therapy on sexual psychophysiology and behaviour in postmenopause. J. Womens Health Gend. Based Med. 99( Suppl. 1), S25–S32 (2000), published erratum: J. Womens Health Gend. Based Med. 10, 91 (2001).
   Google Scholar
• North American Menopause Society. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women. 2007 position statement of The North American Menopause Society. Menopause 14, 355–369 (2007).
   PubMed Web of Science ®Google Scholar
• Pandit L, Ouslander JG. Postmenopausal vaginal atrophy and atrophic vaginitis. Am. J. Med. Sci. 314, 228–231 (1997).
   PubMed Web of Science ®Google Scholar
• Bachmann GA, Leiblum SR, Kemmann E, Colburn DW, Swartzman L, Sheldon R. Sexual expression and its determinants in the postmenopausal woman. Maturitas 6, 19–29 (1984).
   PubMed Web of Science ®Google Scholar
• Bachmann G, Cheng RJ, Rovner E. Vulvovaginal complaints. In: Treatment of the Postmenopausal Woman. Lobo RA ( Ed.). Elsevier, NY, USA 263–269 (2007).
   Google Scholar
• Bachmann GA, Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. Am. Fam. Physician 61, 3090–3096 (2000).
   PubMed Web of Science ®Google Scholar
• Levine KB, Williams RE, Hartmann KE. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause 15, 661–666 (2008).
   PubMed Web of Science ®Google Scholar
• Silvinia W. Climacteric sexuality. Climacteric 13(84–85), 1367–1377 (2011).
   Google Scholar
• Davis SR, Guay AT, Shifren JL, Mazer NA. Endocrine aspects of female sexual dysfunction. J. Sex. Med. 1, 82–86 (2004).
   PubMed Web of Science ®Google Scholar
• Basson R, Brotto LA, Laan E, Redmond C, Utian WH. Assessment and management of women’s sexual dysfunctions: problematic desire and arousal. J. Sex. Med. 2, 291–300 (2005).
   PubMed Web of Science ®Google Scholar
• Alexander JL, Kotz K, Dennerstein L, Kutner SJ, Wallen K, Notelovitz M. The effects of postmenopausal hormone therapies on female sexual dysfunctioning: a review of double-blind, randomized controlled trials. Menopause 11(6 Pt 2), 749–765 (2004).
   PubMed Web of Science ®Google Scholar
• Buster JE, Kingsberg SA, Aguirre O et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet. Gynecol. 105, 944–952 (2005).
   PubMed Web of Science ®Google Scholar
• Nappi R, Salonia A, Traish AM et al. Clinical biologic pathophysiologies of women’s sexual dysfunction. J. Sex. Med. 2, 4–25 (2005).
   PubMed Web of Science ®Google Scholar
• Guthrie JR, Dennerstein L, Taffe JR, Lehert P, Burger HG. The menopausal transition: A 9-year prospective population-based study. The Melbourne Women’s Midlife Health Project. Climacteric 7, 375 (2004).
   PubMed Web of Science ®Google Scholar
• Overlie I, Moen MH, Morkrid L, Skjaeraasen JS, Holte A. The endocrine transition around menopause – a five-year prospective study with profiles of gonadotrophins, estrogens, androgens and SHBG among healthy women. Acta Obstet. Gynecol. Scand. 78, 642 (1999).
   PubMed Web of Science ®Google Scholar
• Mant J, Painter R, Vessey M. Epidemiology of genital prolapse: observations from the Oxford Family Planning Association study. Br. J. Obstet. Gynaecol. 104, 579–585 (1997).
   PubMedGoogle Scholar
• Mokrzycki M, Mittal K, Smilen S, Blechman A, Porges R, Demopolous R. Estrogen and progesterone receptors in the uterosacral ligament. Obstet. Gynecol. 90, 402–404 (1997).
   PubMed Web of Science ®Google Scholar
• Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet. Gynecol. 89, 501–506 (1997).
   PubMed Web of Science ®Google Scholar
• Norton PA, Baker JE, Sharp H, Warenski JC. Genitourinary prolapse and joint hypermobility in women. Obstet. Gynecol. 85, 225–228 (1995).
   PubMed Web of Science ®Google Scholar
• Jackson S, Avery N, Eckford S, Tariton J, Abrams P, Bailey A. Changes in metabolism of collagen in genitourinary prolapse. Lancet 347, 1658–1661 (1996).
   PubMed Web of Science ®Google Scholar
• Keane D, Sims T, Abrams P, Bailey A. Analysis of collagen status in premenopausal nulliparous women with genuine stress incontinence. Neurourol. Urodyn. 11, 300–301 (1992).
   Google Scholar
• Rechberger T, Postawski K, Jakowicki JA, Gunja-Smith Z, Woessner JF. Role of fascial collagen in stress urinary incontinence. Am. J. Obstet. Gynecol. 179, 1511–1514 (1998).
   PubMed Web of Science ®Google Scholar
• Fitzgerald MP, Mollenhauer J, Hale DS, Benson JT, Brubaker L. Urethral collagen morphologic characteristics among women with genuine stress incontinence. Am. J. Obstet. Gynecol. 182, 1565–1574 (2000).
   PubMed Web of Science ®Google Scholar
• Weber AM and Ritcher HE. Pelvic organ prolapse. Obstet. Gynecol. 106, 615 (2005).
   PubMed Web of Science ®Google Scholar
• Iwahashi M, Muragaki Y. Decreased type III collagen expression in human uterine cervix of prolapse uteri. Exp. Ther. Med. 2, 271–274 (2011).
   Google Scholar
• Liu X, Zhao Y, Pawlyk B et al. Failure of elastic fiber homeostasis leads to pelvic floor disorders. Am. J. Pathol. 168, 519 (2006).
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Yamamoto M, Akazawa K et al. Decrease in elastin gene expression and protein synthesis in fibroblasts derived from cardinal ligaments of patients with prolapsus uteri. Cell Biol. Int. 21, 605 (1997).
   Google Scholar
• Goepel C. Differential elastin and tenascin immunolabeling in the uterosacral ligaments in postmenopausal women with and without pelvic organ prolapse. Acta Histochem. 110, 204 (2008).
   PubMed Web of Science ®Google Scholar
• Moon YJ, Choi JR, Jeon MJ et al. Alteration of elastin metabolism in women with pelvic organ prolapse. Am. J. Urol. 185, 1786–179 (2011).
   Google Scholar
• Ottesen B. Vasoactive intestinal polypeptide as a neurotransmitter in the female genital tract. Am. J. Obstet. Gynecol. 147, 208–224 (1983).
   PubMedGoogle Scholar
• Hu JM, Wang L, Cheng X, Zhou LH, Li ZG. Neuropeptide Y innervation in the vaginal mucosa among patients with pelvic organ prolapse. Mol. Med. Rep. 5, 444–448 (2012).
   Google Scholar
• Wald A. Clinical Practice: faecal incontinence in adults. N. Engl. J. Med. 356, 1648–1655 (2007).
   PubMed Web of Science ®Google Scholar
• Perry S, Shaw C, McGrother C et al. Prevalence of fecal incontinence in adults aged 40 years or more living in the community. Gut 50, 480–484 (2002).
   PubMed Web of Science ®Google Scholar
• Pretlove SJ, Radley S, Toozs-Hobson PM et al. Prevalence of anal incontinence according to age and gender: a systematic review and meta-regression analysis. Int. Urogynecol. J. Pelvic Floor Dysfunction 17, 407–417 (2006).
   Google Scholar
• Whitehead WE, Borrud L, Goode PS et al. Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology 137, 512–517 (2009).
   PubMed Web of Science ®Google Scholar
• Nelson R, Norton N, Cautley E, Furner S. Community-based prevalence of anal incontinence. JAMA 274, 559–561 (1995).
   PubMed Web of Science ®Google Scholar
• Lacima G, Pera M, Valls-Sole J et al. Electrophysiologic studies and clinical findings in females with combined fecal and urinary incontinence: a prospective study. Dis. Colon Rectum 49, 353–359 (2000).
   Google Scholar
• Bohle B, Belvis F, Vial M et al. Menopause and obstetric history as risk factors for fecal incontinence in women. Dis. Colon Rectum 54, 8 (2011).
   Google Scholar
• Goh JT. Biomechanical and biochemical assessments for pelvic organ prolapse. Curr. Opin. Obstet. Gynecol. 15, 391–394 (2003).
   PubMed Web of Science ®Google Scholar
• Mac Bride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Concise review for clinicians. Mayo Clinic Proc. 85(1), 87–94 (2010).
   PubMed Web of Science ®Google Scholar